Results 21 to 30 of about 5,906 (249)

Severe hypophosphataemia and hypocalcaemia following intravenous ferric derisomaltose and denosumab administration. [PDF]

BMJ Case Rep
Serum calcium and phosphorus levels are tightly regulated by the calciotropic hormone parathyroid hormone, fibroblast growth factor 23 and 1,25(OH)2 vitamin D.
Kritzinger J, Wyse J, Karaplis A.
europepmc   +2 more sources

Hypophosphataemia in Critical Illness: A Narrative Review. [PDF]

J Clin Med
Phosphate is a predominately intracellular anion that has several key roles in normal cellular functions. Derangements in serum phosphate concentration occur frequently during critical illness, particularly hypophosphataemia, which has been reported in ...
Ramanan M, Tabah A, Affleck J, Edwards F, White KC, Attokaran A, Laupland K.   +6 more
europepmc   +2 more sources

Characterization of serum phosphate levels over time with intravenous ferric carboxymaltose versus placebo as treatment for heart failure with reduced ejection fraction and iron deficiency: An exploratory prospective substudy from HEART-FID. [PDF]

Eur J Heart Fail
Changes in serum phosphate levels over time with ferric carboxymaltose (FCM) in a randomized, double‐blind, prospective substudy of HEART‐FID assessing the following outcomes: serum phosphate, 1,25 dihydroxyvitamin D, 25‐hydroxyvitamin D levels and plasma levels of intact parathyroid hormone during 6 months subsequent to FCM infusion.
Nouhravesh N, Garg J, Rockhold FW, De Pasquale CG, O'Meara E, Lewis GD, Butler J, Harrington J, Ezekowitz JA, Ponikowski P, Troughton RW, Wong YW, Blackman N, Numan S, Adamczyk R, Hernandez AF, Mentz RJ.   +16 more
europepmc   +2 more sources

Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status

BMC Gastroenterology, 2020
Background Intravenous iron replacement is recommended for iron-deficient patients with inflammatory bowel disease (IBD), but may be associated with hypophosphataemia, predisposing to osteomalacia and fractures. This study aimed to evaluate the incidence
Wendy Fang, Rachel Kenny, Qurat-ul-Ain Rizvi, Lawrence P. McMahon, Mayur Garg   +4 more
doaj   +1 more source

High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23 [PDF]

, 2016
Background: Fumaric acid esters (FAEs), an oral immunomodulating treatment for psoriasis and multiple sclerosis, have been anecdotally associated with proximal renal tubular dysfunction due to a drug-induced Fanconi syndrome.
Bark, L.-Ã. (Lars-Ãke), Dahlerup, J.F. (Jens Frederik), Jacobsen, B.A. (Bent A.), Lindgren, S. (Stefan), Thomsen, L.L. (Lars L.), van der Woude, J. (Janneke)   +5 more
core   +8 more sources

Hyperventilation and hypophosphataemia [PDF]

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2009
We describe a case where extensive investigations were utilized to identify the aetiology of hypophosphataemia in a patient presenting with non-specific symptoms. The diagnosis of hyperventilation-induced hypophosphataemia was eventually established. Hyperventilation is a relatively common cause of isolated hypophosphataemia, but is easily overlooked ...
B N, Datta, M D, Stone
openaire   +2 more sources

Clinical guidelines for burosumab in the treatment of XLH in children and adolescents: British paediatric and adolescent bone group recommendations

Endocrine Connections, 2020
X-linked hypophosphataemia (XLH) is caused by a pathogenic variant in the PHEX gene, which leads to elevated circulating FGF23. High FGF23 causes hypophosphataemia, reduced active vitamin D concentration and clinically manifests as rickets in children ...
Raja Padidela, Moira S Cheung, Vrinda Saraff, Poonam Dharmaraj   +3 more
doaj   +1 more source

Correcting hypophosphataemia in a paediatric patient with Sanjad–Sakati syndrome through a single oral dose of potassium phosphate intravenous solution

SAGE Open Medical Case Reports, 2021
Sanjad–Sakati syndrome is an autosomal recessive disorder that is quite common in Kuwait. Among a wide range of complications in Sanjad–Sakati syndrome patients is the vulnerability to infections and subsequent hypophosphataemia.
Mnaff A Sabti, Yousif A Shamsaldeen
doaj   +1 more source

Treating ‘osteoporosis’: a near miss in an unusual case of FGF-23-mediated hypophosphataemic osteomalacia

Endocrinology, Diabetes & Metabolism Case Reports, 2022
We present the case of a 60-year-old female who developed repeated atraumatic stress fractures. She was initially diagnosed with osteoporosis based on her dual-energy X-ray absorptiometry (DXA) scan bone mineral density (BMD) T-scores and started on ...
Mike Lin, Kirtan Ganda
doaj   +1 more source

Postoperative hypophosphataemia

Journal of British Surgery, 1979
Summary The possible mechanisms of postoperative hypophosphataemia were studied in women undergoing uncomplicated cholecystectomy. Six patients were allocated to each of three groups. Group I received no intravenous fluids, group II received dextrose/saline solution alone and group III received dextrose/saline solution with phosphorus ...
P C, England, M, Duari, D E, Tweedle, R A, Jones, E, Gowland   +4 more
openaire   +2 more sources